Insider Ledger
Surgery Partners, Inc. (SGRY) insider buying and SEC filings
Surgery Partners, Inc. · CIK 1638833
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Services-General Medical & Surgical Hospitals, NEC
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$161K
Insiders who bought
1
Sold (not marked 10b5-1)
$1.3M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 18, 2026 | Purchase (code P) Amended filing | Teresa DeLuca (Director) bought 11,250 shares at about $14.33 ($161K), reported as a purchase (code P). Holdings up 20% to 68,093 shares. Not marked as a 10b5-1 plan trade. This amends a filing from Aug 19. | SEC filing Filed Aug 20, 2026 |
| Mar 16, 2026 | Sale | David T Doherty (CFO) sold 8,867 shares at about $12.50 ($111K). Holdings down 4% to 221,679 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 16, 2026 |
| Mar 16, 2026 | Sale | Jason Eric Evans (CEO) sold 20,400 shares at about $12.47 ($254K). Holdings down 2% to 920,386 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 16, 2026 |
| Mar 13, 2026 | Sale | Danielle Burkhalter (Chief Human Resources Officer) sold 3,469 shares at $12.83 ($45K). Holdings down 4% to 76,864 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 16, 2026 |
| Mar 13, 2026 | Sale | Marissa Brittenham (Chief Strategy Officer) sold 3,657 shares at $12.54 ($46K). Holdings down 4% to 94,196 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 16, 2026 |
| Mar 12, 2026 | Sale | Jennifer Baldock (Chief Admin & Dev Officer) sold 5,798 shares at about $13.17 ($76K). Holdings down 2% to 326,474 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 16, 2026 |
| Mar 6, 2026 | Sale | Jason Eric Evans (CEO) sold 11,462 shares at about $13.79 ($158K). Holdings down 2% to 662,680 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 6, 2026 | Sale | David T Doherty (CFO) sold 14,574 shares at about $13.84 ($202K). Holdings down 14% to 88,803 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 6, 2026 | Sale | Jennifer Baldock (Chief Admin & Dev Officer) sold 10,082 shares at $13.70 ($138K). Holdings down 3% to 332,272 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 6, 2026 | Sale | Danielle Burkhalter (Chief Human Resources Officer) sold 7,736 shares at about $13.60 ($105K). Holdings down 17% to 37,103 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 5–6, 2026 | Sale | William Trenton Webb (President / COO) sold 2,066 shares between Mar 5 and Mar 6 at about $13.87 ($29K). Holdings down 3% to 74,249 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
| Mar 6, 2026 | Sale | Marissa Brittenham (Chief Strategy Officer) sold 8,785 shares at $13.70 ($120K). Holdings down 14% to 54,623 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 9, 2026 |
16 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow SGRY in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.